Eli Lilly hopes the device can be more convenient for Zepbound users and lead to more people taking the drug.

Kiniksa Pharmaceuticals, Ltd. (NASDAQ:KNSA) Q4 2025 Earnings Call Transcript February 24, 2026 Kiniksa Pharmaceuticals, Ltd.

The drugmaker unveiled a new Zepbound delivery system as its main rival absorbed fresh clinical and stock-market blows. It’s ...

Feb 25 (Reuters) - British luxury car maker Aston Martin will cut its workforce by up to 20%, it said on Wednesday, as it ...

Nifty traded below 25,450 mark. Auto shares declined after advancing in the past two consecutive trading sessions.

Stock market today: The Indian stock market is likely to open higher on Thursday, February 26, driven by global market cues.

Lilly launches four-dose Zepbound KwikPen in the US. Self-pay starter price begins at $299 per month. Move aims to improve ...

In a phase 2 trial, patients having an urticaria exacerbation who used the spray report better hive and pruritus scores than ...

An independent informational overview of MEDVi's compounded tirzepatide telehealth program, including regulatory ...

Good morning, and welcome to Ionis' Fourth Quarter and Full Year 2025 Financial Results Conference Call. As a reminder, this call is being recorded. At this time, I would like to turn the call over to ...

Discover the top 3 undervalued Pharmaceuticals stocks for Wednesday, February 25 based on AAII’s Stock Grades.

Aston Martin plans up to 20% job cuts, trims EV investments, and aims to recover from tariffs and weak demand in China.